| Gene symbol | LY9 | Synonyms | CD229, SLAMF3, hly9, mLY9 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q23.3 | dbXrefs | |
| Description | lymphocyte antigen 9 | ||||
| GTO ID | GTC0865 |
| Trial ID | ChiCTR2000033568 |
| Disease | Hematologic Cancer |
| Altered gene | SLAMF3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | SLAMF3 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical study for anti-SLAMF3 CAR-T in the treatment of refractory or recurrent SLAMF3+ hematological malignancies |
| Year | 2020 |
| Country | China |
| Company sponsor | The Affiliated Hospital of Xuzhou Medical University |
| Cohort 1 | |||||||
|
|||||||